Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy
Clinical trial NCT02262832 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02262832
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-09
- Primary completion
- 2027-07-31
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.